Pliant Therapeutics, Inc.PLRXNASDAQ
Loading
EV/EBITDA Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

Latest
-0.39
↑ 100% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
-638.32
Historical baseline
PeriodValueYoY Change
2025-0.39+89.7%
2024-3.83+40.0%
2023-6.39+4.3%
2022-6.68-45.6%
2021-4.59+75.5%
2020-18.76+99.7%
2019-5693.90-59038.3%
2018-9.63-1251.5%
2017-0.71-